Bevacizumab/ranibizumab/triamcinoloneEndophthalmitis: 21 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1377卷 / 1期

关键词：

Patient Outcome; Visual Acuity; Bevacizumab; Congenital Anomaly; Macular Oedema;

D O I：

10.2165/00128415-201113770-00027

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：11 / 11

相关论文

共 50 条

[21] Ranibizumab and Bevacizumab for AMD REPLY
Martin, Daniel F.
Maguire, Maureen G.
Fine, Stuart L.
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (23): : 2237 - 2237
[22] Bevacizumab versus Ranibizumab for AMD
Rosenfeld, Philip J.
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20): : 1966 - 1967
[23] Aflibercept/ranibizumab/spironolactoneLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 30 - 30
[24] Lasting Controversy on Ranibizumab and Bevacizumab
Zou, Lihui
Lai, Huiying
Zhou, Qi
Xiao, Fei
THERANOSTICS, 2011, 1 : 395 - 402
[25] Bevacizumab/cetuximabPulmonary toxicities: 3 case reports
Reactions Weekly, 2021, 1868 (1) : 113 - 113
[26] Bevacizumab/carmustineVarious toxicities: 8 case reports
Reactions Weekly, 2018, 1690 (1) : 43 - 43
[27] Bevacizumab/doxorubicinMyelosuppression and hypertension: 3 case reports
Reactions Weekly, 2022, 1888 (1) : 103 - 103
[28] Bevacizumab/fluorouracilOral mucositis: 3 case reports
Reactions Weekly, 2011, 1370 (1) : 11 - 11
[29] Bevacizumab/ifosfamide/sorafenibNeurotoxicity: 3 case reports
Reactions Weekly, 2012, 1409 (1) : 15 - 15
[30] Bevacizumab/doxorubicinCardiac toxicities: 6 case reports
Reactions Weekly, 2012, 1405 (1) : 11 - 11

← 1 2 3 4 5 →